Mar 08, 2011 07:30 EST Olink Bioscience now offers a new research service, Plasma Biomarker Discovery Service. Using the multiplexed PLA® immunoassay platform, up to 74 potential cancer biomarkers are analyzed with high sensitivity in precious biobanked plasma samples, in no more than 2 µl of sample. This enables identification of novel biomarkers and contributies to the understanding of human cancer.
Tag: vinnova
Press Releases
Sep 14, 2009 02:48 EDT Olink Bioscience and its sister company Olink Genomics is participating in the project “Companion Diagnostics Initiative” which is financed by Vinnova and aims to develop improved cancer diagnostics to increase survival rate of patients with colorectal cancer.
Contact persons
Previously Dr Gullberg worked for 10 years at Uppsala University where he also earned his Ph.D. The focus of his work since 1999 has been proximity ligation, rolling circle amplification and selector technology, all core technologies of Olink Bioscience.
